FDA-NOI-SS-1243371.pdf

PDF 87 KB Posted

Attached to
Notice of Intent to Sole Source Federal contract opportunity
Solicitation number
FDA-NOI-SS-1243371
Issued by
Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services

View the file

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Notice of Intent to Sole Source

Date: July 14, 2021

Notice of Intent to Sole Source

Notice ID: FDA-NOI-SS-1243371

Subject: “Preventative Maintenance Agreement for the TESCAN XMU Scanning Electron Microscope (SEM) for a Base Period of One Year (12 Months) and Four (One Year) Options, totaling 5 years for the life of the contract.”, to be Sole Sourced to the TESCAN USA Inc., under solicitation RFQ-FDA-1243371

The U.S. Food & Drug Administration (FDA) intends to issue a Sole Source follow-on award to TESCAN USA, Inc. (“TESCAN”) for Preventative Maintenance Services. The Government intends to issue a sole source award in accordance with FAR 6.302-1, only one responsible source and no other will satisfy the agency requirements for the above stated service.

TESCAN is the manufacturer of TESCAN MIRA-3 GMU Scanning Electron Microscope (SEM). As such, supplies, accessories and parts required to service and/or upgrade the instrument can be obtained, installed, and guaranteed in the USA only from TESCAN USA Inc. Further, TESCAN is also sole source for proprietary software required to operate and/or upgrade the software in the MIRA SEM. No other vendor can provide maintenance and technical support for this system.

This will be a firm fixed price award.

The NAICS Code is: 811219 Other Electronic and Precision Equipment Repair and Maintenance.

TESCAN USA Inc.

765 Commonwealth Drive – Suite 101 Warrendale, PA 15086-7520 USA

This notice of intent is not a request for competitive quotes. However, all responsible sources may submit a capability statement to Sarah Hussain, sarah.hussain@fda.hhs.gov in writing and must be within seven

(7) days after date of publication of this notice which may be considered by the agency. A determination by the Government not to compete as a result of information received is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.

No phone calls will be accepted.

File details come from the government source that posted it. Updated .